Fritextsökning
Artiklar per år
Innehållstyper
-
Changeable proteins cause nerve disease
An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all the time and only certain types contribute to the harmful protein accumulations that cause the ALS disease.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
Filter tips for safer pipetting and better accuracy
Biohit has launched new Safetyspace Filter Tips that have more space between the sample and the filter than conventional filter tips usually have.
-
BMAs: Run your own business
After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project between Swedish public actors and some companies aims to change that and make entrepreneurs of BMAs.
-
Platform for high security virus purification
Millipore Corporation has introduced the Viresolve Pro Solution system, a new system for purification of viruses. The technology in the new platform includes a novel patent pending membrane.
-
Integrerat optiskt svepelektronmikroskop
Jeol lanserar ett hybridmikroskop som kombinerar ljusmikroskopi med atmosfärisk svepelektronmikroskopi.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
How to get the most out of the fair
-
From planning stage to handshake
"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.
-
Viktiga taggsidor
-
Pengar och support på önskelistan
I senaste Scanbaltrapporten identifierar organisationen fem huvudområden för att förbättra förutsättningarna inom life scienceindustrin i länderna kringa Baltikum. -Självklart siktar vi högt, säger Scanbalts generaldirektör Peter Frank.
-
Här blir innovationer business
Som en del i regeringens strategi för entreprenörskap startas två spetsutbildningar inom entreprenörskap och innovation. Utbildningarna hamnar i Göteborg och i Lund.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.
-
En affärsmodell på väg att dö
"Let us be lovers, we'll marry our fortunes together. I've got some real estate here in my bag", Det luspanka unga bussluffarparet i Simon & Garfunkels "America" lovar varandra dyrt och heligt vad som idag är i princip ingenting, men som man hoppas ska
-
Nya blodtrycksgener identifierade
Åtta hittills okända gener som påverkar blodtrycket har kartlagts i en stor internationell studie.
-
De är bäst på patent
En internationell undersökning placerar Awapatent som nummer ett bland Sveriges patentbyråer.
-
Instrument för skräddarsydd behandling snart här
En apparat stor som en mobiltelefon kan komma att revolutionera förskrivningen av läkemedel.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be re-elected at the AGM in May.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.